MA21448A1 - Procede de preparation de structures peptidiques et immunogenes les contenant destines au controle de la fertilite. - Google Patents

Procede de preparation de structures peptidiques et immunogenes les contenant destines au controle de la fertilite.

Info

Publication number
MA21448A1
MA21448A1 MA21691A MA21691A MA21448A1 MA 21448 A1 MA21448 A1 MA 21448A1 MA 21691 A MA21691 A MA 21691A MA 21691 A MA21691 A MA 21691A MA 21448 A1 MA21448 A1 MA 21448A1
Authority
MA
Morocco
Prior art keywords
peptide
preparation
structures containing
fertility control
immunogenic structures
Prior art date
Application number
MA21691A
Other languages
English (en)
Inventor
Jean-Michel Bidari
Original Assignee
Lafon Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Pharma filed Critical Lafon Pharma
Publication of MA21448A1 publication Critical patent/MA21448A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA21691A 1987-11-26 1988-11-24 Procede de preparation de structures peptidiques et immunogenes les contenant destines au controle de la fertilite. MA21448A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716420A FR2623715B1 (fr) 1987-11-26 1987-11-26 Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite

Publications (1)

Publication Number Publication Date
MA21448A1 true MA21448A1 (fr) 1989-07-01

Family

ID=9357207

Family Applications (1)

Application Number Title Priority Date Filing Date
MA21691A MA21448A1 (fr) 1987-11-26 1988-11-24 Procede de preparation de structures peptidiques et immunogenes les contenant destines au controle de la fertilite.

Country Status (22)

Country Link
US (1) US5496551A (fr)
EP (1) EP0323769B1 (fr)
JP (1) JP2509312B2 (fr)
KR (1) KR890008171A (fr)
CN (1) CN1034208A (fr)
AP (1) AP71A (fr)
AT (1) ATE102957T1 (fr)
AU (1) AU617716B2 (fr)
DE (1) DE3888509T2 (fr)
DK (1) DK660888A (fr)
EG (1) EG18596A (fr)
ES (1) ES2052762T3 (fr)
FR (1) FR2623715B1 (fr)
IE (1) IE883545L (fr)
IL (1) IL88381A (fr)
MA (1) MA21448A1 (fr)
NO (1) NO885231L (fr)
NZ (1) NZ227073A (fr)
OA (1) OA08971A (fr)
PT (1) PT89053B (fr)
TN (1) TNSN88129A1 (fr)
ZA (1) ZA888733B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9001709A (nl) * 1990-07-27 1992-02-17 Stichting Centr Diergeneeskund Peptiden en farmaceutische preparaten met een glycoprotene hormoon agonistische of antagonistische werking.
WO1994020859A1 (fr) * 1993-03-11 1994-09-15 Laboratoire L. Lafon TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
FR2702494B1 (fr) * 1993-03-11 1995-06-09 Lafon Labor Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
FR2710845B1 (fr) * 1993-10-08 1996-03-29 Lafon Labor Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
IL140984A0 (en) * 1998-07-23 2002-02-10 Lilly Co Eli Fsh and fsh variant formulations, products and methods
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
DK159276C (da) * 1980-03-31 1991-02-18 Takeda Chemical Industries Ltd Fremgangsmaade til isolering af specifikke antistoffer og enzym-immunbestemmelsesmetode med anvendelse af det isolerede antistof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0142387A1 (fr) * 1983-08-26 1985-05-22 Anda Biologicals Procédé de préparation de vaccins spécifiques pour LH et HCG et procédé pour leur détection
CA1239346A (fr) * 1985-06-04 1988-07-19 Gursaran P. Talwar Vaccin anticonceptionnel
EP0224574A4 (fr) * 1985-06-04 1988-04-26 Biotech Res Partners Ltd Vaccins auto-antigenes.
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides

Also Published As

Publication number Publication date
ES2052762T3 (es) 1994-07-16
IL88381A0 (en) 1989-06-30
OA08971A (fr) 1990-11-30
CN1034208A (zh) 1989-07-26
DK660888A (da) 1989-05-27
US5496551A (en) 1996-03-05
JP2509312B2 (ja) 1996-06-19
DE3888509T2 (de) 1994-10-06
IL88381A (en) 1993-03-15
JPH01301696A (ja) 1989-12-05
FR2623715A1 (fr) 1989-06-02
IE883545L (en) 1989-05-26
NZ227073A (en) 1990-06-26
EP0323769A1 (fr) 1989-07-12
EP0323769B1 (fr) 1994-03-16
DE3888509D1 (de) 1994-04-21
PT89053B (pt) 1993-04-30
KR890008171A (ko) 1989-07-10
TNSN88129A1 (fr) 1990-07-10
NO885231D0 (no) 1988-11-24
ATE102957T1 (de) 1994-04-15
NO885231L (no) 1989-05-29
EG18596A (en) 1993-07-30
AU2596888A (en) 1989-06-01
DK660888D0 (da) 1988-11-25
AP71A (en) 1990-02-24
AP8800110A0 (en) 1989-01-31
FR2623715B1 (fr) 1990-12-21
AU617716B2 (en) 1991-12-05
PT89053A (pt) 1988-12-01
ZA888733B (en) 1990-08-29

Similar Documents

Publication Publication Date Title
NL990002I1 (nl) Rechtsdraaiend enenantiomeer van alfa (4,5,6,7-tetrahydrothienoÄ3,2-cÄ007fÜ-pyrid-5-yl)(2-chloorfenyl) methylacetaat, werkwijze voor de bereiding daarvan en deze bevattende farmaceutische preparaten.
EP0263569A3 (en) 9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
MA21169A1 (fr) Acides desoxyribonucleiques et procede de preparation des proteines qui en derivant.
NO823674L (no) Derivater av cis, endo-2-azabicyklo-(3.3.0)-oktan-3-3-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
FI891338A0 (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
NO901430D0 (no) Fremgangsmaate til fremstilling av 4(3h)-pteridioner, og medikamenter inneholdende slike.
NO176922C (no) Fremgangsmåte for fremstilling av bifunksjonelle proteiner
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
NO873183D0 (no) Fremgangsmaate til fremstilling av reninhemmende di- og tri-peptider.
MA21448A1 (fr) Procede de preparation de structures peptidiques et immunogenes les contenant destines au controle de la fertilite.
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FR2594847B1 (fr) Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant
IT8522144A0 (it) Procedimento per l'essiccazione rapida di ceramica e impianto per realizzarlo.
PT84933B (fr) Procede de preparation de cyclodepsipeptides et compositions pharmaceutiques qui les contiennent
FR2630735B1 (fr) Procede de preparations d'halogenophenols
NO874888D0 (no) Fremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
NO875499D0 (no) Fremgangsmaate og blanding for kontroll og rensning av syresoel.
RO87709A (fr) Procede pour la preparation des 1,1-alcandiols-carboxyliques
IT8767940A0 (it) Procedimento microbiologico per lapreparazione di 9 alfa -idrossi4-androstene-3,17 dione
NO873069D0 (no) Fremgangsmaate for fremstilling av hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere.
NO158299C (no) Analogifremgangsmaate for fremstilling av 17, 18-dehydro-apovincaminol-l-3', 4', 5'-trimethoxy-benzoat.
MX15990A (es) Derivados de acido 3-pirrolidiniltio-1- azabiciclo(3.2.0)hept-2-eno-2-carboxilico, su obtencion y usos.
IT8221787A0 (it) Procedimento per la preparazione di antigene superficiale puro dell'epatite b da plasma umano.